BIOMAT Database Logo BIOMAT Database Logo

Design and synthesis of hydroxyferroquine derivatives with antimalarial and antiviral activities. 2006

Christophe Biot, and Wassim Daher, and Natascha Chavain, and Thierry Fandeur, and Jamal Khalife, and Daniel Dive, and Erik De Clercq
Unité de Catalyse et Chimie du Solide - UMR CNRS 8181, ENSCL, Bâtiment C7, USTL, B.P. 90108, 59652 Villeneuve d' Ascq Cedex, France. christophe.biot@ensc-lille.fr

Three ferroquine (FQ) derivatives, closely mimicking the antimalarial drug hydroxychloroquine (HCQ), have been prepared. Whereas these organometallic compounds provide the expected reduced cytotoxic effects compared to FQ, they inhibit in vitro growth of Plasmodium falciparum far better than chloroquine (CQ). Moreover, this new class of bioorganometallic compounds exert antiviral effects with some selectivity toward SARS-CoV infection. These new drugs may offer an interesting alternative for Asia where SARS originated and malaria has remained endemic.

UI MeSH Term Description Entries
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D011804 Quinolines
D005296 Ferrous Compounds Inorganic or organic compounds that contain divalent iron. Compounds, Ferrous
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000962 Antimalarials Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) Anti-Malarial,Antimalarial,Antimalarial Agent,Antimalarial Drug,Anti-Malarials,Antimalarial Agents,Antimalarial Drugs,Agent, Antimalarial,Agents, Antimalarial,Anti Malarial,Anti Malarials,Drug, Antimalarial,Drugs, Antimalarial
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D045473 Severe acute respiratory syndrome-related coronavirus A species of CORONAVIRUS causing atypical respiratory disease (SEVERE ACUTE RESPIRATORY SYNDROME) in humans. The organism is believed to have first emerged in Guangdong Province, China, in 2002. The natural host is the Chinese horseshoe bat, RHINOLOPHUS sinicus. HCoV-SARS,SARS Virus,SARS-Associated Coronavirus,SARS-CoV,SARS-CoV-1,SARS-like coronavirus,SARSr-CoV,SARSrCoV,Sarbecovirus,Severe Acute Respiratory Syndrome Virus,Severe acute respiratory syndrome coronavirus,SARS Coronavirus,SARS-Related Coronavirus,Urbani SARS-Associated Coronavirus,Coronavirus, SARS,Coronavirus, SARS-Associated,Coronavirus, SARS-Related,Coronavirus, Urbani SARS-Associated,SARS Associated Coronavirus,SARS Related Coronavirus,SARS like coronavirus,SARS-Associated Coronavirus, Urbani,SARS-like coronaviruses,SARSrCoVs,Sarbecoviruses,Severe acute respiratory syndrome related coronavirus,Urbani SARS Associated Coronavirus

Related Publications

Christophe Biot, and Wassim Daher, and Natascha Chavain, and Thierry Fandeur, and Jamal Khalife, and Daniel Dive, and Erik De Clercq
Design, synthesis, antiviral activities of ferulic acid derivatives.
January 2023, Frontiers in pharmacology,
Christophe Biot, and Wassim Daher, and Natascha Chavain, and Thierry Fandeur, and Jamal Khalife, and Daniel Dive, and Erik De Clercq
Design, Synthesis, and Antiviral Activities of New Benzotriazole-Based Derivatives.
March 2023, Pharmaceuticals (Basel, Switzerland),
Christophe Biot, and Wassim Daher, and Natascha Chavain, and Thierry Fandeur, and Jamal Khalife, and Daniel Dive, and Erik De Clercq
Design, Synthesis, and Antiviral Activities of Coumarin Derivatives Containing Dithioacetal Structures.
January 2020, Journal of agricultural and food chemistry,
Christophe Biot, and Wassim Daher, and Natascha Chavain, and Thierry Fandeur, and Jamal Khalife, and Daniel Dive, and Erik De Clercq
Design, synthesis, and antiviral activities of 1,5-benzothiazepine derivatives containing pyridine moiety.
January 2017, European journal of medicinal chemistry,
Christophe Biot, and Wassim Daher, and Natascha Chavain, and Thierry Fandeur, and Jamal Khalife, and Daniel Dive, and Erik De Clercq
Synthesis, antimalarial and antitubercular activities of meridianin derivatives.
June 2015, European journal of medicinal chemistry,
Christophe Biot, and Wassim Daher, and Natascha Chavain, and Thierry Fandeur, and Jamal Khalife, and Daniel Dive, and Erik De Clercq
Synthesis and antimalarial activities of fluoroalkyl derivatives of dihydroartemisinin.
October 1998, Journal of medicinal chemistry,
Christophe Biot, and Wassim Daher, and Natascha Chavain, and Thierry Fandeur, and Jamal Khalife, and Daniel Dive, and Erik De Clercq
Unambiguous synthesis and prophylactic antimalarial activities of imidazolidinedione derivatives.
October 2005, Journal of medicinal chemistry,
Christophe Biot, and Wassim Daher, and Natascha Chavain, and Thierry Fandeur, and Jamal Khalife, and Daniel Dive, and Erik De Clercq
Synthesis and antimalarial activities of several fluorinated artemisinin derivatives.
September 1995, Journal of medicinal chemistry,
Christophe Biot, and Wassim Daher, and Natascha Chavain, and Thierry Fandeur, and Jamal Khalife, and Daniel Dive, and Erik De Clercq
Design, synthesis and antimalarial evaluation of novel thiazole derivatives.
August 2016, Bioorganic & medicinal chemistry letters,
Christophe Biot, and Wassim Daher, and Natascha Chavain, and Thierry Fandeur, and Jamal Khalife, and Daniel Dive, and Erik De Clercq
1,2,4-Triazole and benzimidazole fused dihydropyrimidine derivatives: Design, green synthesis, antibacterial, antitubercular, and antimalarial activities.
April 2023, Archiv der Pharmazie,
Copied contents to your clipboard!